target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id Kir4.1,438,P49655,Rat,Ba2+,2344,,104810,,,,Channel blocker,Antagonist,,,,3-1000,,,,,,,,,=,,,,10856114|7608203|12456399, Kir4.1,438,P49655,Rat,H+,2346,,1038,,,,Gating inhibitor,Antagonist,,yes,,,pEC50,6.1,,6.0,,,,,=,,,Intracellular,11306656|10764726, Kir4.1,438,P49655,Rat,Cs+,2356,,104967,,,,Channel blocker,Antagonist,,,,30-300,,,,,,,,,=,,,,7608203, Kir4.1,438,P78508,Human,nortriptyline,2404,,4543,CNCCC=C1c2ccccc2CCc2c1cccc2,"InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3",PHVGLTMQBUFIQQ-UHFFFAOYSA-N,Channel blocker,Antagonist,,,,,pKd,4.8,,4.4,,,,,=,,,,17071817, Kir4.1,438,P78508,Human,VU0134992,11821,,1319582,CC(C)c1cc(Br)c(OCC(=O)NC2CC(C)(C)NC(C)(C)C2)cc1,"InChI=1S/C20H31BrN2O2/c1-13(2)14-7-8-17(16(21)9-14)25-12-18(24)22-15-10-19(3,4)23-20(5,6)11-15/h7-9,13,15,23H,10-12H2,1-6H3,(H,22,24)",OTTDLWFVHQYRDA-UHFFFAOYSA-N,Channel blocker,Antagonist,,,,,pIC50,,6.01,,IC50,,970.0,,=,Determined using whole-cell patch-clamp electrophysiology,,,29895592,